"Supratentorial Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Primary and metastatic (secondary) tumors of the brain located above the tentorium cerebelli, a fold of dura mater separating the CEREBELLUM and BRAIN STEM from the cerebral hemispheres and DIENCEPHALON (i.e., THALAMUS and HYPOTHALAMUS and related structures). In adults, primary neoplasms tend to arise in the supratentorial compartment, whereas in children they occur more frequently in the infratentorial space. Clinical manifestations vary with the location of the lesion, but SEIZURES; APHASIA; HEMIANOPSIA; hemiparesis; and sensory deficits are relatively common features. Metastatic supratentorial neoplasms are frequently multiple at the time of presentation.
Descriptor ID |
D015173
|
MeSH Number(s) |
C04.588.614.250.195.885 C10.228.140.211.885 C10.551.240.250.700
|
Concept/Terms |
Supratentorial Neoplasms- Supratentorial Neoplasms
- Supratentorial Tumors
- Supratentorial Tumor
- Tumor, Supratentorial
- Tumors, Supratentorial
- Neoplasms, Supratentorial
- Neoplasm, Supratentorial
- Supratentorial Neoplasm
Cancer, Supratentorial- Cancer, Supratentorial
- Cancers, Supratentorial
- Supratentorial Cancer
- Supratentorial Cancers
- Supratentorial Neoplasms, Malignant
- Malignant Supratentorial Neoplasms
- Malignant Supratentorial Neoplasm
- Neoplasm, Malignant Supratentorial
- Neoplasms, Malignant Supratentorial
- Supratentorial Neoplasm, Malignant
Primary Supratentorial Neoplasms- Primary Supratentorial Neoplasms
- Neoplasm, Primary Supratentorial
- Neoplasms, Primary Supratentorial
- Primary Supratentorial Neoplasm
- Supratentorial Neoplasm, Primary
- Supratentorial Neoplasms, Primary
Benign Supratentorial Neoplasms- Benign Supratentorial Neoplasms
- Benign Supratentorial Neoplasm
- Neoplasm, Benign Supratentorial
- Neoplasms, Benign Supratentorial
- Supratentorial Neoplasm, Benign
- Supratentorial Neoplasms, Benign
|
Below are MeSH descriptors whose meaning is more general than "Supratentorial Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Supratentorial Neoplasms".
This graph shows the total number of publications written about "Supratentorial Neoplasms" by people in this website by year, and whether "Supratentorial Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Supratentorial Neoplasms" by people in Profiles.
-
Lee JC, Koo SC, Furtado LV, Breuer A, Eldomery MK, Bag AK, Stow P, Rose G, Larkin T, Sances R, Kleinschmidt-DeMasters BK, Bodmer JL, Willard N, Gokden M, Dahiya S, Roberts K, Bertrand KC, Moreira DC, Robinson GW, Mo JQ, Ellison DW, Orr BA. Concurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangement. Acta Neuropathol Commun. 2024 Sep 03; 12(1):143.
-
Wang HC, Hertzog JH, O'Donnell HD, Walter AW. Natural progression of an unresected supratentorial ependymoma. Pediatr Neurosurg. 2008; 44(1):75-8.
-
Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys. 2004 Nov 1; 60(3):853-60.
-
Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer. 1996 Apr 15; 77(8):1535-43.